Mostrando 5 resultados de: 5
Subtipo de publicación
Article(5)
Publisher
Cardiovascular Diabetology(1)
Diabetes Care(1)
European Heart Journal(1)
JAMA Internal Medicine(1)
The Lancet Diabetes and Endocrinology(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Medicina y salud(2)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Associations of Fish Consumption with Risk of Cardiovascular Disease and Mortality among Individuals with or without Vascular Disease from 58 Countries
ArticleAbstract: Importance: Cohort studies report inconsistent associations between fish consumption, a major sourcePalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., Dehghan M., DIaz R., Gerstein H.C., Gulec S., Gupta R., Hu W., Iqbal R., Kaur M., Khatib R., Lanas F.T., Lear S.A., Mente A., Mohammadifard N., Mohan D., Mohan V., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Swaminathan S., Szuba A., Teo K.K., Vijayakumar K., Wei L., Wentzel-Viljoen E., Wielgosz A., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusContrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: Cohort study data from 143,567 individuals in 21 countries in the pure study
ArticleAbstract: OBJECTIVE We aimed to compare cardiovascular (CV) events, all-cause mortality, and CV mortality ratePalabras claves:Autores:Alhabib K.F., Anjana R.M., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Gerstein H.C., Gupta R., Hu L., Iqbal R., Iype T., Karsidag K., Kruger L., Lakshmi P.V.M., Lanas F.T., Lear S.A., Mohan V., Mony P.K., Noorhassim I., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rahman M.O., Rangarajan S., Rosengren A., Sheridan P., Teo K.K., Venkatesan U., Wei L., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusErectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
ArticleAbstract: Background: Diabetes is a major risk factor for erectile dysfunction, however, the effect of GLP-1 rPalabras claves:Autores:Bajaj H.S., Basile J.N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., Franek E., Gerstein H.C., Hanefeld M., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Rydén L.E., Shaw J.E., Sheu W.H.H., Xavier D.Fuentes:googlescopusSimilar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin
ArticleAbstract: Objective : Recent European Guidelines for Diabetes, Pbkp_rediabetes and Cardiovascular Diseases intPalabras claves:Cardiovascular disease, GLP-1-based therapy, Metformin, Morbidity, MortalityAutores:Avezum A.J., Basile J.N., Colhoun H.M., Cushman W.C., Dagenais G.R., DIaz R., Dyal L., Ferrannini G., Gerstein H.C., Jansky P., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Mellbin L., Pais P., PATRICIO LOPEZ -JARAMILLO, PīrCrossed D Sign gs V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H.Fuentes:googlescopusTotal cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
ArticleAbstract: Background: The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) doublePalabras claves:Cardiovascular disease, Glucagon like peptide-1 receptor agonists, Type 2 DiabetesAutores:Atisso C.M., Basile J.N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., Dyal L., Gerstein H.C., Hall S., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.Fuentes:googlescopus